Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Propylone

From Wikipedia, the free encyclopedia

Pharmaceutical compound
Propylone
Clinical data
Other names3,4-Methylenedioxy-N-propylcathinone; MD-PrC; PrONE; bk-3,4-MDPA
Drug classMonoamine releasing agent;Monoamine reuptake inhibitor
Identifiers
  • 1-(1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one
CAS Number
PubChemCID
ChemSpider
UNII
Chemical and physical data
FormulaC13H17NO3
Molar mass235.283 g·mol−1
3D model (JSmol)
  • CCCNC(C)C(=O)C1=CC2=C(C=C1)OCO2
  • InChI=1S/C13H17NO3/c1-3-6-14-9(2)13(15)10-4-5-11-12(7-10)17-8-16-11/h4-5,7,9,14H,3,6,8H2,1-2H3
  • Key:YFVKHKCZBSGZPE-UHFFFAOYSA-N

Propylone, also known as3,4-methylenedioxy-N-propylcathinone is a mixedmonoamine releasing agent andreupake inhibitor of thecathinone family related tomethylone andethylone.[1]

It acts specifically as a weakpartialserotonin–dopamine releasing agent (SDRA) andserotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI), withEC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) values for induction of monoamine release of 3,128 nM (30%) forserotonin and 976 nM (20%) fordopamine, andIC50Tooltip half-maximal inhibitory concentration value for monoamine reuptake inhibition of 2,462 nM for serotonin, 28,540 nM for norepinephrine, and 1,863 nM for dopamine.[1]

The drug was first described in the literature in a 1996patent byAlexander Shulgin andPeyton Jacob III.[2] It was subsequently characterized more thoroughly by 2015[1] and was encountered as a noveldesigner drug inEurope by 2016.[3][4][5]

See also

[edit]

References

[edit]
  1. ^abcSakloth F (11 December 2015).Psychoactive synthetic cathinones (or 'bath salts'): Investigation of mechanisms of action.Theses and Dissertations (Ph.D. thesis). Virginia Commonwealth University.doi:10.25772/AY8R-PW77. Retrieved24 November 2024 – via VCU Scholars Compass.
  2. ^WO 1996039133, Jacob III P, Shulgin AT, "Preparation of novel N-substituted-2-amino-3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents.", published 12 December 1996, assigned to Neurobiological Technologies, Inc. 
  3. ^"EMCDDA–Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA".Europol. 23 October 2018. Retrieved11 March 2025.
  4. ^Liu C, Jia W, Li T, Hua Z, Qian Z (August 2017). "Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP".Drug Test Anal.9 (8):1162–1171.doi:10.1002/dta.2136.PMID 27863142.
  5. ^Pulver B, Fischmann S, Gallegos A, Christie R (December 2024)."EMCDDA framework and practical guidance for naming cathinones".Drug Test Anal.16 (12):1409–1435.doi:10.1002/dta.3662.PMC 11635063.PMID 38389255.

External links

[edit]


DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous


Stub icon

Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Propylone&oldid=1281102492"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp